Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancers|February 27, 2026
miRNA-Based Breast Cancer Subtyping Using AHALA Multi-Stage Classification ApproachMohammed Qaraad, Eric P Rahrmann, David Guinovart
Nature Reviews. Cancer|July 24, 2023
Cancers make their own luck: theories of cancer originsAmir Jassim, Eric P Rahrmann, Ben D Simons, et al.
Medical Research Archives|February 7, 2025
Osteosarcoma: A comprehensive review of model systems and experimental therapiesGabrielle M Robbins, Young Y Vue, Eric P Rahrmann, et al.
Iscience|August 5, 2024
NF1-dependent disruption of the blood-nerve-barrier is improved by blockade of P2RY14Jennifer Patritti-Cram, Eric P Rahrmann, Tilat A Rizvi, et al.
Nucleic Acids Research|February 28, 2013
Modular assembly of transposon integratable multigene vectors using RecWay assemblyBranden S Moriarity, Eric P Rahrmann, Vincent W Keng, et al.
Life Science Alliance|September 25, 2023
KCNQ potassium channels modulate Wnt activity in gastro-oesophageal adenocarcinomasDavid Shorthouse, Lizhe Zhuang, Eric P Rahrmann, et al.
Cancer Research|June 16, 2012
PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumorsVincent W Keng, Eric P Rahrmann, Adrienne L Watson, et al.
Scientific Reports|August 14, 2014
Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemiaSusan K Rathe, Branden S Moriarity, Christopher B Stoltenberg, et al.
Plos One|May 7, 2014
Simple and efficient methods for enrichment and isolation of endonuclease modified cellsBranden S Moriarity, Eric P Rahrmann, Dominic A Beckmann, et al.
Sarcoma|January 16, 2013
Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNSTVincent W Keng, Adrienne L Watson, Eric P Rahrmann, et al.
Pageof 3